Search

everythinglearnresearchcommunity

for

Search:↓

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Tofacitinib is effective and safe for treating severe alopecia areata.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Erlotinib can cause unexpected side effects like eyelash growth and scarring.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Abrocitinib may effectively treat stubborn alopecia universalis.

Upadacitinib effectively treats pyoderma gangrenosum.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.